Optic nerve and neuroprotection strategies NN Osborne, G Chidlow, CJ Layton, JPM Wood, RJ Casson, J Melena Eye 18 (11), 1075-1084, 2004 | 153 | 2004 |
Current Evidence for the Prevention of Endophthalmitis in Anti‐VEGF Intravitreal Injections PET Lau, KS Jenkins, CJ Layton Journal of ophthalmology 2018 (1), 8567912, 2018 | 76 | 2018 |
Survey of eye practitioners’ attitudes towards diagnostic tests and therapies for dry eye disease AW Turner, CJ Layton, AJ Bron Clinical & experimental ophthalmology 33 (4), 351-355, 2005 | 72 | 2005 |
Retinal explant culture: a platform to investigate human neuro‐retina A Murali, CA Ramlogan‐Steel, S Andrzejewski, JC Steel, CJ Layton Clinical & experimental ophthalmology 47 (2), 274-285, 2019 | 66 | 2019 |
Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: trials, future directions and safety considerations CA Ramlogan‐Steel, A Murali, S Andrzejewski, B Dhungel, JC Steel, ... Clinical & Experimental Ophthalmology 47 (4), 521-536, 2019 | 65 | 2019 |
The effect of insulin and glucose levels on retinal glial cell activation and pigment epithelium-derived fibroblast growth factor-2 CJ Layton, S Becker, NN Osborne Molecular vision 12, 46-54, 2006 | 43 | 2006 |
Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy G de Moraes, CJ Layton Clinical & Experimental Ophthalmology 44 (9), 838-852, 2016 | 41 | 2016 |
Oscillatory potentials and the b-Wave: partial masking and interdependence in dark adaptation and diabetes in the rat CJ Layton, R Safa, NN Osborne Graefe's archive for clinical and experimental ophthalmology 245, 1335-1345, 2007 | 37 | 2007 |
Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review AYL Goh, CJ Layton Clinical & Experimental Ophthalmology 44 (6), 509-519, 2016 | 27 | 2016 |
Monocarboxylate transporter expression remains unchanged during the development of diabetic retinal neuropathy in the rat CJ Layton, G Chidlow, RJ Casson, JPM Wood, M Graham, NN Osborne Investigative ophthalmology & visual science 46 (8), 2878-2885, 2005 | 26 | 2005 |
Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma LCJSJC Dhungel B, Jayachandran A Drug Delivery 24 (1), 289-299, 2017 | 21 | 2017 |
The impact of ultraviolet radiation on the aetiology and development of uveal melanoma M Chalada, CA Ramlogan-Steel, BP Dhungel, CJ Layton, JC Steel Cancers 13 (7), 1700, 2021 | 20 | 2021 |
Neuronal death in primary retinal cultures is related to nitric oxide production, and is inhibited by erythropoietin in a glucose‐sensitive manner CJ Layton, JPM Wood, G Chidlow, NN Osborne Journal of neurochemistry 92 (3), 487-493, 2005 | 19 | 2005 |
Clinical aspects of conjunctival melanoma C Layton, W Glasson Clinical & Experimental Ophthalmology 30 (2), 72-79, 2002 | 19 | 2002 |
Presence and prevalence of UV related genetic mutations in uveal melanoma: similarities with cutaneous melanoma. AY Goh, CA Ramlogan-Steel, KS Jenkins, JC Steel, CJ Layton Neoplasma 67 (5), 2020 | 18 | 2020 |
Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma B Dhungel, S Andrzejewski, A Jayachandran, R Shrestha, ... Gene Therapy 25 (2), 115-128, 2018 | 15 | 2018 |
Diabetic levels of glucose increase cellular reducing equivalents but reduce survival in three models of 661W photoreceptor-like cell injury CJ Layton BMC ophthalmology 15, 1-9, 2015 | 15 | 2015 |
Factors associated with significant ocular injury in conservatively treated orbital fractures CJ Layton Journal of ophthalmology 2014 (1), 412397, 2014 | 14 | 2014 |
Neutralisation of adeno-associated virus transduction by human vitreous humour S Andrzejewski, PM Moyle, BW Stringer, JC Steel, CJ Layton Gene Therapy 28 (5), 242-255, 2021 | 9 | 2021 |
miRNA122a regulation of gene therapy vectors targeting hepatocellular cancer stem cells B Dhungel, CA Ramlogan-Steel, CJ Layton, JC Steel Oncotarget 9 (34), 23577, 2018 | 9 | 2018 |